# A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis

> **NCT00678795** · PHASE3 · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 135 (actual)

## Conditions studied

- Detrusor Overactivity
- Multiple Sclerosis

## Interventions

- **DRUG:** Sativex®
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00678795
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2023-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00678795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00678795, "A Parallel Group Study to Compare Sativex® With Placebo in the Treatment of Detrusor Overactivity in Patients With Multiple Sclerosis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00678795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*